IDH1 and diffuse astrocytoma: Korshunov et al. describe the use of the KIAA1549:BRAF fusion to distinguish PAs from R132H IDH1 mutation positive diffuse astrocytoma counterparts with high specificity, with a consistent lack of R132H IDH1 mutation positivity in PAs (49).